Method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide
AssigneeDong-A Pharmaceutical. Co., Ltd
InventorsHyun Hee Kwak, Ghun II Lee, Yong Man Park, Mi Kyung Son, Hi Chang Yang, Tae Hyoung Kim, Yoon Ji Kim, Byong Moon Kim, Sung Hee Lee, Soo Hyung Kang, Moohi Yoo
Disclosed are biodegradable microspheres, capable of releasing a glucose-regulating peptide in a controlled manner, comprising a biodegradable polymer carrier with the glucose -regulating peptide encapsulated therein, and methods for the preparation thereof. In addition to ensuring high encapsulation efficiency and high stability of the encapsulated drug, the microspheres shows neither an initial burst effect nor incomplete release and allows the zero -order release of drugs over a prolonged period of time, thus improving the therapeutic effect of the drug.
Drawings
Claims16
A method for preparing a biodegradable polymer microsphere containing a glucose-regulating peptide, comprising:
(a) an organic solvent to a polymer to yield a polymer solution;
(b) dispersing a glucose-regulating peptide in the polymer solution of step (a) to yield a drug dispersion;
(c) mixing an alcohol or a mixture of an alcohol and an organic acid with the drug dispersion to yield a drug-dispersed solution;
and
(d) producing a microsphere from the drug-dispersed solution of (c),
wherein the alcohol of step (c) is used at a ratio of 1:1˜1:6 (v/v) of the alcohol:
18 Apr 2028Estimated · howhide20 years from earliest known nonprovisional domestic filing plus recorded patent term adjustment. Maintenance-fee lapses, terminal disclaimers and statutory extensions have not been checked. The continuity chain may be incomplete; this is not an enforceability determination.
Drugs for disorders of the metabolism: for glucose homeostasis
Life of this patent
About 1 year 6 months of term left · ends 18 Apr 2028 (estimated)
Priority, Korea19 Apr 2007
Filed18 Apr 2008
Published27 May 2010
Granted9 Oct 2012
Today12 Oct 2026
Term ends18 Apr 2028
Priority, Korea19 Apr 2007
Granted9 Oct 2012
Term ends18 Apr 2028
Priority claimedKR 10-2007-0038467
Application filedUS 12/595,434
Assigned to Dong-A Pharmaceutical. Co., Ltdassignment of assignor's interest
PublishedUS 2010/0129459 A1
GrantedUS 8,282,990 B2
TodayWithin its term
Term endsEstimated
Description5,665 words
Summary1,494 words
#This application is a 371 of PCT/KR2008/002216 filed on Apr. 18, 2008, which claims the benefit of Korean Patent Application No. 10-2007-0038467 filed on Apr. 19, 2007, the contents of each of which are incorporated herein by reference.
#The present invention relates to a biodegradable polymeric microsphere comprising a biodegradable polymer carrier with a glucose-regulating peptide encapsulated therein, capable of releasing the glucose-regulating peptide in a controlled manner, and a method for the preparation thereof.
#After being administered orally, most protein and peptide drugs lose their active structures in the acidic environment of the stomach or undergo enzymatic degradation. Also, they are adsorbed at very low rates through the gastric or intestinal mucosa. For these reasons, protein or peptide drugs usually take non-oral administration routes, that is, are usually administered by injection. The non-oral administration of protein or peptide drugs must be repeated because most non-orally administered protein or peptide drugs show short half lives and low bioavailability in the body. In addition, their administration may be continued for a long time period, e.g., months, in many cases. In order to avoid these problems, active research into sustained-release dosage formulations has been conducted, resulting in the use of biodegradable polymeric carriers with protein or peptide drugs encapsulated therein, which can release the protein or peptide drugs therefrom as the biodegradation of the polymeric carriers progresses [Heller, J. et al., Controlled release of water-soluble macromolecules from bioerodible hydrogels, Biomaterials, 4, 262-266, 1983; Langer, R., New methods of drug delivery, Science, 249, 1527-1533, 1990; Langer, R., Chem. Eng. Commun., 6, 1-48, 1980; Langer, R. S. and Peppas, N. A., Biomaterials, 2, 201-214, 1981; Heller, J., CRC Crit. Rev. Ther. Drug Carrier Syst., 1(1), 39-90, 1984; Holland, S. J. Tighe, B. J. and Gould, P. L., J. Controlled Release, 155-180, 1986].
Brief description of the drawings5 figures
#FIG. 1 is a graph showing the in vitro release pattern of the microspheres prepared through a drug dispersion process in Example 1 in accordance with the present invention.
#FIG. 2 is a graph showing the in vitro release patterns of the microspheres prepared in Examples 4 to 8 in accordance with the present invention.
#FIG. 3 is a graph showing the in vitro release patterns of the microspheres prepared in Comparative Examples 1 and 2.
Detailed description4,056 words
#Below, a detailed description is given of the present invention.
#The present invention pertains to a biodegradable polymeric microsphere for the controlled release of a glucose-regulating peptide, comprising a biodegradable polymer carrier with the glucose-regulating peptide encapsulated therein.
#Examples of the glucose-regulating peptide suitable for use in the present invention include natural, recombinant or synthetic exendin-3, exendin-4 and homologs and agonists thereof, glucagon, glucagon-like peptides (e.g., GLP-1, GLP-2) and homologs and agonists thereof, with preference for synthetic exendin-3, exendin-4 and homologs and agonists thereof. Most preferable is synthetic exendin-4.